S&P 500 Futures
(-0.01%) 5 307.50 points
Dow J Futures
(0.00%) 40 144 points
Nasdaq Futures
(-0.01%) 18 502 points
Oil
(1.32%) $82.42
Gas
(-1.51%) $1.692
Gold
(1.82%) $2 230.40
Silver
(0.02%) $24.76
Platinum
(0.31%) $912.50
USD/EUR
(0.35%) $0.927
USD/NOK
(0.56%) $10.83
USD/GBP
(0.12%) $0.792
USD/RUB
(-0.26%) $92.20

Realtime updates for Paradigm [PAR.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 01:10

0.00% $ 0.345

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 01:10):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Paradigm Biopharmaceuticals Ltd

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia...

Stats
Today's Volume 292 755
Average Volume 700 252
Market Cap 106.93M
EPS $0 ( 2024-02-29 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.500
ATR14 $0.00200 (0.57%)

Volume Correlation

Long: -0.03 (neutral)
Short: 0.41 (neutral)
Signal:(53.176) Neutral

Paradigm Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Paradigm Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.36
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.53
( weak negative )

Paradigm Financials

Annual 2023
Revenue: $46 760.00
Gross Profit: $-125 723 (-268.87 %)
EPS: $-0.180
Q2 2023
Revenue: $0
Gross Profit: $-73 397.00 (0.00 %)
EPS: $-0.160
Q4 2023
Revenue: $42 050.00
Gross Profit: $-46 172.00 (-109.80 %)
EPS: $-0.0692
Q2 2023
Revenue: $4 710.00
Gross Profit: $-79 551.00 (-1 688.98 %)
EPS: $-0.120

Financial Reports:

No articles found.

Paradigm

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators